Vishal V. Singh
Varanasi, UP 221005, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Integrative behavioral, histological, and proteomics profiling identifies cerebellar drivers of motor dysfunction in a rat model of hepatic encephalopathy.
Journal: Metabolic brain disease
Published: June 22, 2025
Microbiota dysbiosis impact on the immune system dysregulation in Huntington's disease (HD).
Journal: International review of neurobiology
Published: May 25, 2025
Correction to: Investigating cognitive impairments and hippocampal proteome alterations in aged male rats with TAA-induced minimal hepatic encephalopathy.
Journal: Biogerontology
Published: April 07, 2025
Investigating cognitive impairments and hippocampal proteome alterations in aged male rats with TAA-Induced minimal hepatic encephalopathy.
Journal: Biogerontology
Published: September 18, 2024
ATI Stabilized Germylene Cation as a Cyanosilylation Catalyst for Aldehydes and Ketones.
Journal: Chemistry, an Asian journal
Published: February 07, 2024
Identification of potential regulatory mechanisms and therapeutic targets for lung cancer.
Journal: Journal of biomolecular structure & dynamics
Published: February 06, 2024
Elucidating hippocampal proteome dynamics in moderate hepatic encephalopathy rats: insights from high-resolution mass spectrometry.
Journal: Experimental brain research
Published: January 31, 2024
Modulation of brain energy metabolism in hepatic encephalopathy: impact of glucose metabolic dysfunction.
Journal: Metabolic brain disease
Published: January 29, 2024
Structural and thermostability insights into cellobiohydrolase of a thermophilic mould Myceliophthora thermophila: in-silico studies.
Journal: Journal of biomolecular structure & dynamics
Published: October 14, 2022
Recent development of multi-targeted inhibitors of human topoisomerase II enzyme as potent cancer therapeutics.
Journal: International journal of biological macromolecules
Published: August 30, 2022
WITHDRAWN: In-Silico Study of Resveratrol as Multi-Edged Potent Inhibitor against SARSCov- 2 and Variants of Concern Using Molecular Dynamic Simulation and PCA Analysis
Journal: Current pharmaceutical design
Published: August 04, 2022
Last Updated: 09/26/2026